Articles by The Wall Street Analyzer
EastGate Biotech Files Application to Initiate Phase III Clinical Trial for Insugin
Approximately 200 patients will be included in the Phase III study in order to achieve regulatory approval in Pakistan […]
Scottie Resources Corp. (TSXV: SCOT) Management Interview
Natural Shrimp, Inc’s (OTC: SHMP) Patented Technology is in Place and the Company is Ready for Growth
About: NaturalShrimp, Inc. (OTCQB: SHMP) a publicly traded agro-tech company, has developed patented proprietary technology to produce fresh, gourmet-grade shrimp without the use of antibiotics, probiotics or toxic chemicals. NaturalShrimp systems are self-contained, saltwater production […]
Giga-tronics Reports Results for FY 2019 and a Substantial Increase in Revenues and Gross Margins along with positive Operating and Net Income for the Fourth Quarter of FY 2019
Giga-tronics Incorporated (OTCQB: GIGA) (the “Company”) reported net revenue for the fourth fiscal quarter ended March 30, 2019 of $3.5 million, a 50% increase as compared to $2.3 million for the same period of fiscal 2018. […]
CANNTAB SIGNS TERM SHEET WITH HERITAGE FOR PROCESSING HEMP FOR SALE OF CBD FILLED GELCAPS
– Canntab Makes Progress Towards Becoming Revenue-Generating in 2019 –
[…]
Clear Blue Technologies Launches Energy-as-a-Service for Wireless Power
TORONTO, May 22, 2019 (GLOBE NEWSWIRE) — Clear Blue Technologies International Inc. (“Clear Blue” or “the Company”) (TSXV:CBLU) (FRANKFURT:0YA) announced today the launch of its Energy-as-a-Service (EaaS) for wireless power. This new subscription-based service provides […]
Canntab Receives Cultivation Licence for Industrial Hemp
Enables Canntab to Leverage Properties in Saskatchewan and Ontario to Cultivate High Quality Hemp for the Extraction of Cannabidiol (CBD) Additionally, Canntab’s application is currently “In Progress” to obtain a Cannabis Licence (Processing- Standard, Federal […]
EastGate Biotech Announces Preparation to Initiate Phase III Clinical Trials on Insugin, its Liquid Insulin Mouth Rinse for Type 2 diabetes patients
Multi-Center Phase III trial planned for 2019
[…]
